Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

National Center For Geriatrics And Gerontology patents


Recent patent applications related to National Center For Geriatrics And Gerontology. National Center For Geriatrics And Gerontology is listed as an Agent/Assignee. Note: National Center For Geriatrics And Gerontology may have other listings under different names/spellings. We're not affiliated with National Center For Geriatrics And Gerontology, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | National Center For Geriatrics And Gerontology-related inventors


National Center For Geriatrics And Gerontology

. . ... National Center For Geriatrics And Gerontology

Therapeutic agent for tauopathy and method for screening thereof

The present invention provides a tau protein aggregation inhibitor. In addition, a therapeutic agent or a preventive agent for tauopathy, including a tau protein aggregation inhibitor, and a method for screening for a tau protein aggregation inhibitor, are also provided. ... National Center For Geriatrics And Gerontology

Surrogate biomarker for evaluating intracerebral amyloid ß peptide accumulation and method for analysis thereof

Provided are a biomarker for evaluating a cerebral aβ accumulation state using an amyloid precursor protein (app)-derived peptide in a living body-derived sample as an index, and a method for analysis thereof. A living body-derived sample derived from a test subject is measured, and at least one ratio selected from the group consisting of app669-711/app672-713 (aβ1-42); app672-709 (aβ1-38)/app672-713 (aβ1-42); app674-711 (aβ3-40)/app672-713 (aβ1-42); app672-710 (aβ1-39)/app672-713 (aβ1-42); app672-711 (aβ1-40)/app672-713 (aβ1-42); and app672-711 (oxaβ1-40)/app672-713 (aβ1-42) is calculated, and when each of the ratios of the test subject is higher than each of standard levels which are ratios of a person having normal cognitive function nc− who is negative for cerebral aβ accumulation, an accumulation amount of cerebral aβ of the test subject is determined as larger than an accumulation amount of cerebral aβ of the person having normal cognitive function nc−.. ... National Center For Geriatrics And Gerontology

Pharmaceutical composition capable of accelerated penetration into affected area

Provided is a pharmaceutical composition excellent in capability of an accelerated penetration into an affected area. The pharmaceutical composition capable of accelerated penetration into the affected area is formed by dispersing nano-bubbles, which are negatively charged and are given high internal pressures due to their surface tension, in the pharmaceutical composition in a form of a liquid or a gel including a predetermined drug.. ... National Center For Geriatrics And Gerontology








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with National Center For Geriatrics And Gerontology in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for National Center For Geriatrics And Gerontology with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###